Primo Chemicals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

Net loss reportedExceptional itemEBITDA margin compressionResults View source PDF Explain this filing

PRIMO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.8%Reaction day

₹22.58

prior close

₹22.01

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.5%-1.4% vs market

Commodity Chemicals peers, median of 51sector-0.6%-2.3% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 2.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.2

15m

-1.2

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.8-1.5-1.4-0.6-2.3

Next day

-1.3-2.2+0.9-2.5+1.2

-2.6-1.2-1.3-2.1-0.5

-2.3-0.9-1.4-1.5-0.8

-8.1-2.3-5.8-3.3-4.9

-8.5-2.5-6.0-4.3-4.2

-10.9-3.6-7.3-5.3-5.6

15d

-23.9-10.4-13.5-9.5-14.4

-22.1-11.3-10.8-10.6-11.4

+0.9-3.6+4.4-6.4+7.3

+13.2+3.9+9.3+1.9+11.3

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 51Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Primo Chemicals Limited reported its Q3 FY26 and 9M FY26 unaudited results on 12 February 2026. Standalone revenue from operations for Q3 FY26 was Rs. 14,014 lakhs, down from Rs. 14,385 lakhs in Q3 FY25, while 9M FY26 revenue grew modestly to Rs. 41,683 lakhs from Rs. 40,014 lakhs. Standalone Q3 PAT was a loss of Rs. 34 lakhs (vs profit of Rs. 192 lakhs YoY) due to a one-time Rs. 20 lakh provision for the new Labour Codes, classified as an exceptional item. However, 9M FY26 standalone PAT more than doubled to Rs. 547 lakhs (vs Rs. 347 lakhs in 9M FY25), and consolidated 9M net profit surged to Rs. 930 lakhs from Rs. 397 lakhs, aided by a Rs. 383 lakh share of profit from its 49% associate, Flow Tech Chemicals. The auditor (S. Tandon & Associates LLP) issued a clean limited review report with no qualifications or emphasis of matter.

Likely market impact

The weak Q3 standalone print and YoY EBITDA margin compression (from ~16.3% to ~12.7%) may weigh on sentiment, but strong 9M and consolidated profit growth, driven by the associate, signals improving full-year earnings trajectory for shareholders.